SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000863894-22-000017
Filing Date
2022-12-05
Accepted
2022-12-05 15:23:56
Documents
89
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-K veru-20220930x10k.htm   iXBRL 10-K 3923790
2 EX-4.3 veru-20220930xex4_3.htm EX-4.3 32917
3 EX-21 veru-20220930xex21.htm EX-21 8842
4 EX-23.1 veru-20220930xex23_1.htm EX-23.1 8604
5 EX-31.1 veru-20220930xex31_1.htm EX-31.1 15195
6 EX-31.2 veru-20220930xex31_2.htm EX-31.2 15106
7 EX-32.1 veru-20220930xex32_1.htm EX-32.1 11141
  Complete submission text file 0000863894-22-000017.txt   13498459

Data Files

Seq Description Document Type Size
8 EX-101.SCH veru-20220930.xsd EX-101.SCH 68861
9 EX-101.CAL veru-20220930_cal.xml EX-101.CAL 95799
10 EX-101.DEF veru-20220930_def.xml EX-101.DEF 239906
11 EX-101.LAB veru-20220930_lab.xml EX-101.LAB 560093
12 EX-101.PRE veru-20220930_pre.xml EX-101.PRE 470768
83 EXTRACTED XBRL INSTANCE DOCUMENT veru-20220930x10k_htm.xml XML 2710190
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-13602 | Film No.: 221444763
SIC: 2834 Pharmaceutical Preparations